Submission ID

Submission Date

Full Name

Certifications and Credentials

Job Title

Employer

Address

Work Phone Number

Email Address

Attach curriculum vitae

Attach short biography

Attach publicity photo

Presentation Title

Description of yourpresentation for eventprogram

2018 GAEMS Providers & Educators Conference - Call for Presentations

4009008355676426132

04-30-2018 07:33:57

Michael Frankel

MD

Professor & Director of Vascular Neurology; Chief of Neurology

Emory University School of Medicine; Grady Health System

80 Jesse Hill Jr. Dr. SEAtlantaGeorgia30303United States

(404) 616-0517

mfranke@emory.edu

Michael Frankel CV .pdf

Michael Frankel Bio.docx

Michael Frankel.jpg

The Evolution in Systems of Stroke Care: Taking it to the Streets

The treatment of acute stroke has evolved over the past 30 years. Prior to 1996there was not an FDA-approved treatment for ischemic stroke. Although manyadvances have been made since that time, stroke remains the 5th leading causeof death in the US and a leading contributor to long-term disability. Dr. Frankelwill highlight the evolution of treatment options for acute ischemic stroke toinclude providing care at the earliest possible time - on the patient's doorstep.The learner will also view the project design of Georgia's first Mobile StrokeTreatment Unit and how it impacts Systems of Care.

Objectives of yourpresentation

Date Preferred (check all thatapply)

Time Preferred

Type of Session

Audio Visual EquipmentNeeded

Role Desired

Compensation Agreement

Define ischemic stroke and its impact on mortality & morbidity

Discuss various treatment options for acute stroke

Understand the current pre-hospital management of acute stroke

Identify the role of technology in the treatment of acute stroke

Discuss the international impact made by the mobile stroke treatment unit

Monday, Sept. 24, 2018

Afternoon

General Session (1 hr)

Laptop ComputerComputer ProjectionWireless Lapel Microphone

Regional Speaker

I agree to the above listing of compensation for my role desired, and will not holdGAEMS responsible for fees and expenses above those listed above.

Submission ID

Submission Date

Full Name

Certifications and Credentials

Job Title

Employer

Address

Work Phone Number

Cell Phone Number

Email Address

Attach curriculum vitae

Attach short biography

2018 GAEMS Providers & Educators Conference - Call for Presentations

4009019465671990814

04-30-2018 07:52:27

Carol Fleming

BSN RN CCRN

Outreach Director-Marcus Stroke Network

Grady Health System

80 Jesse Hill Jr. Drive SEAtlantaGeorgia30303United States

(404) 616-0517

(770) 557-4761

cfleming1@gmh.edu

Carol Fleming CV.pdf

Carol Fleming Bio.docx

Attach publicity photo

Presentation Title

Description of yourpresentation for eventprogram

Objectives of yourpresentation

Why you want to speak at theGAEMS EducatorsConference

Grady_Fleming_Headshot.jpg

The Evolution in Systems of Stroke Care: Taking it to the Streets

The treatment of acute stroke has evolved over the past 30 years. Prior to 1996there was no FDA-approved treatment for ischemic stroke. Although manyadvances have been made since that time, stroke remains the 5th leading causeof death in the US and a leading contributor to long-term disability. Dr. Frankelwill highlight the evolution of treatment options for acute ischemic stroke toinclude providing care at the earliest possible time - on the patient's doorstep.The learner will also view the project design of Georgia's first Mobile StrokeTreatment Unit and how it impacts Systems of Care.

Define ischemic stroke and its impact on mortality & morbidity

Discuss various treatment options for acute stroke

Understand the current pre-hospital management of acute stroke

Identify the role of technology in the treatment of acute stroke

Discuss the international impact made by the mobile stroke treatment unit

I have a keen interest in pre-hospital care and how it impacts patient outcomes.Dr. Frankel and I will co-lead this discussion on Stroke, pre-hospitalmanagement and the future of innovative stroke care as it pertains to the pre-hospital provider.

Date Preferred (check all thatapply)

Time Preferred

Type of Session

Audio Visual EquipmentNeeded

Role Desired

Compensation Agreement

Monday, Sept. 24, 2018

Afternoon

General Session (1 hr)

Laptop ComputerComputer ProjectionWireless Lapel Microphone

Regional Speaker

I agree to the above listing of compensation for my role desired, and will not holdGAEMS responsible for fees and expenses above those listed above.

Carol Fleming is the Outreach Director for the new Marcus Stroke Network and has been project manager for the build-out of Georgia’s first Mobile Stroke Treatment Unit. Prior to transitioning to the director role, Carol served as outreach manager for Grady’s Marcus Stroke & Neuroscience Center. She has been the liaison between the MSNC, EMS and 70 partnering hospitals. Since becoming a registered nurse, Carol has gained 20+ years’ clinical experience in critical care, emergency and transport nursing. Her experience in the critical care setting and passion for the pre-hospital environment endorses a holistic understanding for systems of care.

Dr. Michael Frankel is professor of neurology at Emory University School of Medicine, and chief of neurology and director of the Marcus Stroke and Neuroscience Center at Grady Memorial Hospital.

Dr. Frankel has worked in the field of acute stroke research since 1992. He has served as Chief of Neurology for the Grady Health System for the past 20 years, devoting his academic, clinical and research interests to cerebrovascular disease. Under his leadership Grady Memorial Hospital has hosted major clinical trials, including the NIH sponsored t-PA Stroke Trial which led to the FDA approval of t-PA in acute stroke.

P

SKILLS

AFFILIATIONS

WORK H

07/2015 to

09/2005 to

CAROL FLEMING

3271 Woodcliff Way, Powder Springs, GA 30127

Cell: (770) 557-4761 - carol.fleming@rocketmail.com

SUMMARY

Dedicated Nursing Professional with strong leadership and project management skills.

Expert in the detailed skills required to identify opportunities and streamline process

improvement. Proven track record in building professional relationships and growing

business in the competitive healthcare arena.

Project management Client assessment and analysis

Strategic planning Astute to client needs

Process improvement Strong emotional intelligence

Member, Air and Surface Transport Nurses

Member, Association American Association of Critical Care Nurses

2018 Chair, Georgia Stroke Professional Alliance

Outreach Manager

Grady Health System, Marcus Stroke & Neuroscience Center

Monitor all patient transfers and referrals to ensure effective and efficient

processes.

Plan and implement ongoing education to referring hospital partners and EMS

agencies.

Create and maintain regular reports for internal and external partners.

Maintain collaborative relationship medical &research staff, EMS and hospitals.

Extend Grady Health Systems footprint in competitive marketplace.

Project Manager for Mobile Stroke Unit Implementation. Director for Marcus Stroke

Network

Clinical Supervisor-Regional Clinical Compliance Manager

Air Methods Corporation

Direct clinical base education for 20 air medical transport locations and 160 clinicians.

Regulatory oversight of new employees

Business Development Partner for statewide education

Member of National Quality Council to improve patient outcomes

Supervision of base budget, scheduling and daily operations

Successfully grew program with new base openings and same base transports

ROFESSIONAL

ISTORY

Current

03/2017

01/1998 to 08/2006

07/1997 to 12/1997

06/1990 to 06/1997

EDUCATION

Registered Nurse

Atlanta Medical Center

Critical care RN managing patients with traumatic injuries, medical, surgical,

cardiovascular, neurological and neurosurgical conditions.

Resource/Charge nurse of a 37 bed ICU supervising 20+ RNs and support staff.

Preceptor and mentor to new clinicians.

Data collector for research based study drugs and equipment.

St Joseph's Hospital – Atlanta

Critical care RN in Medical CCU caring for patients with cardiac maladies.

Registered Nurse

Winchester Medical Center – Winchester, VA

Registered nurse employed in medical coronary care unit managing patients with

invasive monitoring, Intra-aortic balloon pumps, left ventricular assist devices as well as

maintenance of vasoactive medications.

Associates of Science: Nursing

Shenandoah University - Winchester

Bachelor of Science: Nursing

Georgia Southern University

MICHAEL FRANKEL, M.D.

CURRICULUM VITAE

OFFICE ADDRESS:

Box 036, 11C-030 Telephone: 404-616-4013

Dept. of Neurology Fax: 404-659-0849

Grady Memorial Hospital

80 Jesse Hill Jr. Drive, SE

Atlanta, GA 30303

E-mail ADDRESS: mfranke@emory.edu

CITIZENSHIP: United States of America

CURRENT TITLES AND AFFILIATIONS:

Primary Academic Appointments:

2003 – present Professor of Neurology

Emory University School of Medicine

Clinical Appointments:

2010 – present Director of the Marcus Stroke & Neuroscience Center

Grady Health System

Atlanta, GA

2004 – present Director of Vascular Neurology

Emory University School of Medicine

1992 – present Chief of Neurology

Grady Health System

PREVIOUS ACADEMIC AND PROFESSIONAL APPOINTMENTS:

Academic Appointments:

1998 – 2003 Associate Professor of Neurology

Emory University School of Medicine

1992 - 1998 Assistant Professor of Neurology

Emory University School of Medicine

Training Director Appointments:

2003 – 2012 Fellowship Director

Vascular Neurology

Emory University School of Medicine

LICENSURE/BOARDS:

Georgia Board of Medical Examiners

License number: 034832

Diplomate of the National Board of Medical Examiners

SPECIALTY BOARD CERTIFICATIONS:

1. Neurology, 1993

American Board of Psychiatry & Neurology

2. Clinical Neurophysiology, 1994

American Board of Psychiatry & Neurology

3. Vascular Neurology, 2008

American Board of Psychiatry & Neurology

EDUCATION:

Aug 79-Jul 81 University of Louisville

Aug 81-May 83 B.S. in Biochemistry, Tulane University

MEDICAL EDUCATION:

Aug 83-May 87 M.D., University of Louisville School of Medicine (5/17/1987)

POSTGRADUATE TRAINING:

INTERNSHIP:

Jul 87-Jun 88 Internal Medicine - Emory University School of Medicine

Supervisor: Juha Kokko, M.D., Chairman of Internal Medicine

RESIDENCY:

Jul 88-Jun 91 Neurology - Emory University School of Medicine

Jul 90-Jun 91 Chief Resident in Neurology - Emory University

Supervisor: Mahlon DeLong, M.D., Chairman of Neurology

FELLOWSHIP:

Jul 91-Jun 92 Clinical Neurophysiology (Electroencephalography &

Electromyography) Emory University School of Medicine

Supervisor: Linton Hopkins, M.D., Professor of Neurology

COMMITTEE MEMBERSHIPS:

NATIONAL:

Randomized Trial of Tirilazad in Acute Stroke, NIH Safety & Monitoring Committee,

1996

Steering Committee for the NINDS t-PA Stroke Trial Group (1992 - present).

CV: Michael R. Frankel, M.D.

Page - 3

Publications Committee for the NINDS t-PA Stroke Trial Group, 1992 – present.

Abstract Review Committee for the 22nd International Conference on Stroke, 1997.

Abstract Review Committee for the 23rd International Conference on Stroke, 1998.

Abstract Review Committee for the American Academy of Neurology Meeting -

Cerebrovascular Disease Section, 1998.

Steering Committee for Warfarin vs Aspirin Symptomatic Intracranial Disease Study

(WASID), 1999 to present.

Steering Committee for CDC sponsored, “Paul Coverdell National Acute Stroke

Registry”, Sept 2001 – present.

National Steering Committee for the American Heart/American Stroke Association’s

“Get With The Guidelines” program, June 2004 – present.

National Board of Directors, American Heart Association, 2005-2007.

American Stroke Association National Advisory Committee, 2005-2006.

Joint Commission’s “Technical Advisory Panel” on Comprehensive Stroke Center

Certification, 2013-present

REGIONAL/STATE:

Chairman - Stroke Advisory Committee and Task Force for the American Heart

Association, Georgia Affiliate, July 1997 - 1998.

Member, Stroke Task Force Committee for the Southeastern Affiliate of The American

Heart Association, 1999.

President, Georgia Strike Out Stroke Committee, 1999 to present.

Co-Chairman - The Greater Atlanta Stroke Coalition, 1998-1999.

Co-Chairman - The Metro Atlanta Stroke Task Force, American Heart Association Heart

Association 1999 - 2000.

Member, Minority Involvement Committee, American Heart Association, 1997 - 1999.

Member, Community Advising Committee for the NIH Sponsored Study called

“WASID”.

CV: Michael R. Frankel, M.D.

Page - 4

Member, Georgia Research Consortium Stroke Group, 1999.

Co-Chairman, Operation Stroke for Atlanta, American Stroke Association (AHA), 1999 -

2002.

Co-Chairman, Hospital/EMS subcommittee, Operation Stroke for Atlanta, American

Stroke Association, 1999 - present.

Member, Steering Committee, Operation Stroke for Atlanta, American Stroke

Association, 1999 – present.

Co-Chairman, “Check your pulse America”, National Stroke Association sponsored

campaign to increase detection of atrial fibrillation, July/2000, Atlanta, GA.

Member, LifeLink of Georgia Advisory Board, December, 2001 to 2008.

Member, Tri-State (GA, NC, & SC) Stroke Network, 2001 to present.

Vice President, American Heart Association, Southeast Affiliate (5 states). 2002 – 2003.

“Stroke Champion” for Atlanta for the American Stroke Association’s Beta Pilot called,

“Get With The Guidelines”, 2002 – present.

Member, R. Bruce Logue Advisory Board, 2002-present. The Board selects an award

recipient each year – a physician who has distinguished themself as a healer, scientist,

teacher, leader and humanitarian.

President-elect, American Heart Association, Southeast Affiliate (5 states). 2003 – 2004.

President, American Heart Association, Southeast Affiliate. 2004 – 2005.

Co-Chair, Cultural Initiatives Committee, AHA Southeast Affiliate, 2004 – 2005.

Co-Chair, Stroke Systems of Care Task Force, AHA Greater Southeast Affiliate, 2009-

2011

Member, Remote Stroke Treatment Center Committee for Georgia, 2014-present

Co-Chair, Mission Lifeline for Stroke, AHA Greater Southeast Affiliate, 2015-present

INSTITUTIONAL:

Medical Executive Committee for the Grady Health System, 1992 – present.

Emory Neurology Residency Committee, 1992 – present.

CV: Michael R. Frankel, M.D.

Page - 5

Emory Neurology Medical Student Education Committee, 1996 – present.

Grady Medical Staff By-Laws Committee, 1996 – present.

The Emory Clinical Pathway for Stroke Committee, 1993 – 1995.

Emory University Faculty Senate, 1995.

Steering Committee member for the Warfarin Aspirin Symptomatic Intracranial Disease

(WASID) Trial, 1997 - present.

Group Leader for the Grady Health System Verbal Orders Committee, 1998 - present.

Grady/Emory Relations Committee, 1999.

Member, Grady Health System IRB, 1999 to present.

Member, Grady Research Oversight Committee, 1998 - present.

Group Leader, Grady Stroke Clinical Pathway Committee, 1999 - present.

Group Leader for the Grady Medical Records Delinquency Task Force, 2001.

Chairman, Grady Health System Research Oversight Committee, June 2001 – present.

Member, Executive Committee, Department of Neurology, Emory University, 2002 –

2003.

Member, Emory Medical Care Foundation Research Committee, July 2002 – present.

Member, General Advisory Committee, General Clinical Research Center (GCRC) at

Grady, 2003.

Member, Program Directors’ Committee, Department of Neurology, Emory University,

2004 – present.

Member, Emory University School of Medicine’s Continuing Medical Education

Advisory Committee, 2005 – present.

Chair, Emory University Hospital Multidisciplinary Stroke Committee, 2005 - .

Chair, Emory Healthcare Comprehensive Stroke Center Planning Committee, 2005 - .

Co-Chair, Grady Health System Neuroscience Service Line Committee, 2006 - .

CV: Michael R. Frankel, M.D.

Page - 6

Member, Emory University Hospital – Midtown, Multidisciplinary Stroke Committee,

2011-

Advisory Committee to Emory’s Executive Associate Dean for Grady Affairs

CONSULTANTSHIPS:

Data and Safety Monitoring Committee for the Upjohn sponsored study of Tirilizad in

acute ischemic stroke, 1996.

MANUSCRIPT REVIEWER:

ADHOC reviewer: Neurology, 1996 & 1997; Stroke, 1999 and 2000; The Neurologist,

2000, 2002, 2006, 2007; Journal of Hospital Medicine, 2006

HONORS and AWARDS:

1996 Neurology Faculty Teaching Award, presented by neurology residents.

Best Neurology Faculty Teaching Award – 1999, presented by the Emory University

Medical School graduating class of 1999.

Special Recognition Award for Excellence in Teaching - 1999, presented by neurology

residents.

2002 Neurology Faculty Teaching Award, presented by neurology residents.

2007 Neurology Faculty Teaching Award, presented by neurology residents

2008 Elected to Alpha Omega Alpha (AOA) by Emory Medical Students

SOCIETY MEMBERSHIPS:

American Academy of Neurology

American Neurological Association

American Stroke Association/American Heart Association – Stroke Council

ORGANIZATION OF NATIONAL OR INTERNATIONAL CONFERENCES:

Steering Committee, National Institute of Neurological Disorders and Stroke Symposium:

The Rapid Identification and Treatment of Acute Stroke, 1996.

Co-Chair, Emergency Department Subcommittee for the NINDS Symposium: The Rapid

CV: Michael R. Frankel, M.D.

Page - 7

Identification and Treatment of Acute Stroke, 1996.

Co-Chair, Hospital Care Subcommittee for the NINDS Symposium: The Rapid

Identification and Treatment of Acute Stroke, 1996.

International Advisory Board. The Xth International Symposium on Thrombolysis and

Acute Stroke Therapy in Budapest, Hungary - September 21-23, 2008.

Organizing faculty for the 4th International Conference on Intracranial Atherosclerosis,

Sept/2011, in Valladolid, Spain.

ORGANIZATION OF REGIONAL/STATE CONFERENCES:

Co-Chair, Greater Atlanta Stroke Coalition, 5/98.

Co-Chair, “Stroke Summit 1999", Metro Atlanta Stroke Task Force, American Heart

Association, 5/99.

Co-Chair, “Stroke Summit 2000", Operation Stroke for Atlanta, American Stroke

Association, 5/26/00.

Co-Chair, “Educating Metro-Atlanta Hospitals about Acute Stroke Treatment”, American

Stroke Association, Sheraton Hotel, Atlanta, GA, 1/16/01.

RESEARCH FOCUS:

Research and academic focus has been in the clinical areas of cerebrovascular disease

including clinical trials, acute treatment of stroke, stroke prevention, stroke epidemiology,

stroke recovery, racial differences in stroke, cerebrovascular imaging, outcomes, quality

improvement of stroke, collaborative models of stroke care, biomarkers in stroke and

traumatic brain injury, and clinical trials in traumatic brain injury.

GRANT SUPPORT:

ACTIVE

Federally funded:

Principal Investigator, “NINDS Stroke Trials Network - Regional Coordinating Stroke

Centers (U10)”. Title: “Georgia StrokeNet”. Funded by NIH/NINDS. 1U10NS086607-

01. 9/25/2013-7/31/2018. Award amount: $1,950,000

Principal Investigator, “Biomarkers of Ischemic Outcomes in Symptomatic Intracranial

Stenosis (BIOSIS)”. Funded by NIH/NINDS. 1R01NS064162-01. 7/1/2010 –

CV: Michael R. Frankel, M.D.

Page - 8

6/30/2014. Award amount: $1,474,835. “No-cost” extension phase

Principal Investigator, Biomarkers of Injury and Outcomes in ProTECT III” (BIO-

ProTECT). Funded by NIH/NINDS. 1R01NS071867. 5/1/2010 – 4/30/2015. Award

amount: $2,614,136

Principal Investigatory (for Emory University), “Ethnicity and Race in Intracerebral

Hemorrhage (ERICH)”. Funded by NIH/NINDS 1U01NS069763-01. Subcontract with

University of Cincinnati. 8/1/2011-7/31/2015.

Principal Investigator (for Emory University), “Georgia Coverdell Stroke Registry”.

Funded by CDC/Georgia Dept. of Human Resources. 5/1/2005 – 6/30/2015.

Co-Principal Investigator at Emory University (w/David Wright, Co-PI),

2U10NS059032-06, Neurological Emergencies Treatment Trials (NETT) Network,

sponsored by NIH/NINDS. 2012-2017.

Co-Principal Investigator at Emory University (Stewart Factor, PI). “Network of

Excellence in Neuroscience (NeuroNEXT)”. Funded by NIH/NINDS 5U10NS077366-03 09/01/13 – 06/30/14 0.60 calendar mon

Award amount: $242,052

Site Principal Investigator (Grady Hospital) for the ProTECT III trial (progesterone in

acute TBI), (David Wright, PI), sponsored by NIH/NINDS. 2010-2015.

PREVIOUS SUPPORT:

Federally funded:

Principal Investigator at Emory University for, “Secondary Prevention of Small

Subcortical Strokes (SPS3) study”. Funded by NIH/NINDS, subcontract with UT San

Antonio. 2/1/04 – 2012.

Principal Investigator, “Validation of Stroke Care Quality Indicators for the Paul

Coverdell National Acute Stroke Care Registry”. Funded by CDC/AAMC Cooperative

Agreement, 10/1/05 – 9/30/09.

Principal Investigator, “Track and Improve Outcomes After Stroke”. Funded by

CDC/AAMC Cooperative Agreement, 10/1/04 – 9/30/07.

Principal Investigator at Emory University for, “Ischemic Stroke Genetics Study (ISGS)”.

Funded by NINDS, subcontract with Mayo Clinic. 6/01/05 – 5/31/07.

Principal Investigator at Emory University for, “The Paul Coverdell National Acute

Stroke Registry – Georgia’s Acute Stroke Registry”. 9/1/01-1/31/04. Funded by Centers

for Disease Control and Prevention (CDC).

CV: Michael R. Frankel, M.D.

Page - 9

Co-PI for Progesterone treatment of blunt traumatic brain injury (ProTECT), sponsored

by NIH, 2000 – 2005.

Principal Investigator at Emory University, “Interventional Management of Stroke”,

funded by NINDS, subcontract with University of Cincinnati, 2000 – 2004.

Co-Investigator for Warfarin vs Aspirin in Symptomatic Intracranial Disease (WASID)

study, NINDS sponsored, 1999 – 2005.

Principal Investigator at Emory University, African American Antiplatelet Stroke

Prevention Study sponsored by NIH, 1997 - 2000. Subcontract with Rush-Presbyterian

University.

Subinvestigator, Siblings With Ischemic Stroke Study (SWISS), NIH sponsored,

subcontract with Mayo Clinic, Barney Stern – PI at Emory. 2001 – 2004.

Principal Investigator at Emory University for the NIH/NINDS Sponsored t-PA Stroke

Trial, NO1, 1992 - 1995.

Industry Sponsored:

Co-Investigator, “Trevo Trial”, Phase III study of stent retrieval device in acute ischemic

stroke, Stryker, Inc 2010-2012. (PI: Nogueira).

Principal Investigator at Emory, “SPARCL”, Phase III study of Atorvastatin after TIA or

Ischemic Stroke, Sponsored by Pfizer, 2000 – 2006.

Principal Investigator at Emory University, Citicoline for Acute Ischemic Stroke,

sponsored by Interneuron Pharmaceuticals, 1998.

Principal Investigator at Emory University, Clomethiazole Acute Stroke Study in

Ischemic Stroke (CLASS-I), Clomethiazole Acute Stroke Study - t-PA (CLASS-T), and

Clomethiazole Acute Stroke Study - Hemorrhage (CLASS-H), sponsored by Astra

Pharmaceuticals, 1998.

Principal Investigator at Emory University in the Study of Clopidogrel vs Aspirin in

patients at risk for ischemic events. Sponsored by Sanofi-Winthrop Pharmaceuticals,

1992 - 1996.

Principal Investigator at Emory University for the Emergency Management of Stroke

Bridging Trial. Sponsored by Genentech., 1996.

Principal Investigator at Emory University Cerestat for Acute Ischemic Stroke, sponsored

by Boehringer Ingelheim, 1996 - 1997.

CV: Michael R. Frankel, M.D.

Page - 10

Co-Investigator, Activated Protein C Resistance and Risk of Stroke. Joint Project with

the Center for Disease Control (CDC), 1997 -1999.

Principal Investigator at Emory University, ProUrokinase for Acute Middle Cerebral

Artery Territory Infarction (PROACT) sponsored by Abbott Pharmaceuticals, 1996 -

1999.

Principal Investigator at Emory University, Hu23F2G Anti-adhesion to Limit cytoToxic

injury in Stroke (HALT Study) for Stroke, sponsored by ICOS Corporation, 1997 – 1998.

Principal Investigator at Emory University, Fiblast Stroke Study, sponsored by Wyeth-

Ayerst, 1998.

Foundation Sponsored:

Principal Investigator at Emory University, Cord blood infusion for patients with acute

ischemic stroke. Sponsored by the Marcus Foundation (Joanne Kurtzberg, PI). 2015-

2016.

Other:

Sickle Cell Stroke Prevention Study (The Stop Study), Transcranial Doppler technical

support supervision for Emory, NIH sponsored, first phase, 1995-97.

CLINICAL SERVICE CONTRIBUTIONS:

Established the Marcus Stroke & Neuroscience Center at Grady which opened in

May/2010

FORMAL TEACHING and INVITED LECTURES: (available on request)

INVITATIONS TO NATIONAL OR INTERNATIONAL CONFERENCES

INVITED ORAL PRESENTATIONS:

“Predicting poor prognosis after stroke: Results of a placebo analysis from the NINDS rt-

PA Stroke Study”, oral presentation at the American Academy of Neurology Annual Mtg,

5/2/00.

“Preliminary results from 4 state pilot prototypes of the Paul Coverdell National Acute

Stroke Registry”, oral presentation at the International Stroke Conference, Phoenix, AZ,

2/15/03.

“Preliminary results of the Biomarkers of Ischemic Outcomes in Symptomatic

CV: Michael R. Frankel, M.D.

Page - 11

Intracranial Stenosis (BIOSIS) study”. International Conference on Intracranial Arterial

Disease (ICAD). Houston, TX. Fall/2013.

“Coverdell Stroke Registry”, oral presentation for the Florida-Puerto Rico Stroke

Registry (NINDS sponsored), Sept/2014.

INVITED ATTENDANCE

NINDS Symposium on The Rapid Identification and Treatment of Acute Ischemic

Stroke, 12/96.

American Academy of Neurology Annual Meeting, Minneapolis, April, 1998. Co-Chair

of the Clinical Cerebrovascular Diseases session. (Unable to attend)

American Heart Association Southeastern Affiliate Conference on Stroke, Atlanta, GA,

8/14/98.

American Academy of Neurology Annual Meeting, Toronto, April 1999. Co-Chair of

“Stroke Therapy” oral abstract presentation session.

American Academy of Neurology Annual Meeting, San Diego, May 2000. Co-Chair of

“Cerebral Hemorrhage” oral abstract presentation session.

BIBLIOGRAPHY:

PUBLISHED ARTICLES in REFEREED JOURNALS:

1. Krendel DA, Ditter SM, Frankel MR, Ross WK. Biopsy-proven cerebral vasculitis

associated with cocaine abuse. Neurology 1990;40:1092-1094.

2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

Tissue Plasminogen Activator for Acute Ischemic Stroke, N Engl J Med 1995;333:1581-

7.

3. Qureshi A, Safdar K, Weil J, Barch C, Bliwise D, Colohan A, Mackay B, Frankel MR.

Predictors of Early Deterioration and Mortality in African-Americans after Intracerebral

Hemorrhage. Stroke, Vol 26, No 10, October 1995, 1764-1767.

4. Qureshi A, Frankel MR. Loss of Autoregulation in Patients with Intracerebral

Hemorrhage, J. Stroke Cerebrovasc Dis, Vol 5, No.3, 1995 163-165.

5. Qureshi A, Frankel MR, Ottenlips J, Stern B. Cerebral Hemodynamics in Eclampsia and

Pre-eclampsia. Arch Neurol 1996; 53:1226-1231.

6. Lyden P, Grotta J, Levine S, Marler J, Frankel MR, Brott T. Intravenous Thrombolysis

CV: Michael R. Frankel, M.D.

Page - 12

for Acute Stroke. Neurology 1997; 49:14-29.

7. Qureshi A, Janssen R, Karon J, Weissman JP, Akbar S, Safdar K, Frankel MR. Human

Immunodeficiency Virus Infection and Stroke in Young Patients. Arch Neurol.

1997;54:1150-53.

8. Qureshi A, Muhammed A, Janssen R, Frankel MR. Intracerebral Hemorrhage in Blacks:

Risk Factors Subtypes and Outcome. Stroke 1997; 28:961-64.

9. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA

therapy for ischemic stroke. Stroke 1997;28:2109-2118.

10. The NINDS rt-PA Stroke Study Group. Generalized efficacy of tPA for acute stroke:

Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28:2119-2125.

11. The NINDS rt-PA Stroke Study Group. A systems approach to immedicate evaluation

and management of hyperacute stroke. Experience at 8 centers and implications for

community practice and patient care. Stroke. 1997;28:1530-1540.

12. Qureshi A, Akbar MS, Czander E, Safdar K, Jannsen RS, Frankel MR. Crack Cocaine

Use and Stroke in Young Patients. Neurology 1997; 48:341-45.

13. Fagan SC, Morgenstern LB, Petita A, Ward R, Tilley B, Marler J, Broderick J, Levine

SR, Kwiatkowski T, Frankel MR, Walker MD and the NINDS rt-PA Stroke Trial

Investigators. The cost effectiveness of t-PA for acute ischemic stroke. Neurology

1998;883-890.

14. Qureshi A, Safdar K, Patel M, Jannen RS, Frankel MR. Stroke in Young Black Patients,

Risk Factors, Subtypes and Prognosis, Stroke, Vol 26, No. 11, November 1995, 1995-

1998.

15. Brott T, Kothari R, Fagan S, Frankel MR, et al. Hypertension and its Treatment in the

NINDS t-PA Stroke Study. Stroke, 1998; 29:1504-1509.

16. Qureshi A, Isa A, Cinnamon J, Fountain J, Ottenlips JR, Braimah J, Frankel MR.

Magnetic resonance angiography in patients with brain infarction. Journal of

Neuroimaging, 1998;8:65-70.

17. Lewandowski CA, Frankel MR, Tomsick TA, et al. Combined intravenous and intra-

arterial rt-PA versus intra-arterial therapy of acute ischemic stroke: The Emergency

Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.

18. Qureshi A, Frankel MR, et al. Rate of 24-hour Blood Pressure Decline and Mortality

after spontaneous intracerebral hemorrhage: A retrospective analysis with a random

effects regression model. Intracerebral Hemorrhage and Mortality. Crit Care Med, 1999;

CV: Michael R. Frankel, M.D.

Page - 13

Vol 27, No 3, 480-485.

19. Kwiatkowski TG, Libman R, Frankel MR, Tilley B, Morgenstern LB, Lu M, Broderick

J, Marler J, Brott T, and the NINDS t-PA Stroke Study Group. The NINDS rt-PA stroke

study: The effects of t-PA for acute ischemic stroke at one year. N Engl J Med,

1999;340:1781-7.

20. Grotta JC, Chiu D, Liu M, Patel S, Levine SR, Tilley BC, Brott TG, Haley EC, Lyden

PD, Kothari R, Frankel MR, et al. Agreement and Variability in the Interpretation of

Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy. Stroke,

1999; 30:1528-1533.

21. Qureshi A, Mohammad Y, Yahia AM, Luft AR, Sharma M, Tamargo RJ, Frankel MR.

Ischemic events associated with unruptured intracranial aneurysms: multicenter clinical

study and review of the literature. Neurosurgery 2000; 46(2):282-9.

22. Frankel MR, Morgenstern LB, Kwiatkowski T, Lu M, Tilley BC, Broderick JP, Libman

R, Levine SR, Brott T. Predicting prognosis after stroke, A placebo group analysis from

the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology

2000;55:952-959.

23. Broderick JP, Lu M, Kothari R, Levine SR, Lyden PD, Haley EC, Brott TG, Grotta J,

Tilley BC, Marler JR, Frankel M, and the NINDS rtPA Stroke Study Group. Finding the

Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the

NINDS tPA Stroke Trial. Stroke 2000;31:2335-2341.

24. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR,

Frankel MR, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP for the

NINDS rt-PA Stroke Study Group. Early stroke treatment associated with better

outcome. The NINDS rt-PA Stroke Study. Neurology 2000;55:1649-1655.

25. The NINDS tPA Stroke Study Group. Effect of intravenous tPA on ischemic stroke

lesion size measured by CT: Results from the NINDS tPA Stroke Trial. Stroke 2000; 31:

2912-2919

26. Grotta JC, Welch KMA, Fagan SC, Lu M, Frankel MR, Brott T, Levine SR, and Lyden

PD for the NINDS rt-PA Stroke Study Group. Clinical Deterioration Following

Improvement in the NINDS rt-PA Stroke Trial. Stroke 2001; 32: 661-668.

27. Rowe AK, Frankel MR, Sanders KA. Stroke awareness among Georgia adults:

epidemiology and considerations regarding measurement. Southern Medical Journal

2001:94:613-618.

28. Lyden P, Lu M, Kwiatkowski T, Frankel M, Levine S Broderick J, Brott T, and the

NINDS rt-PA Stroke Study Group. Thrombolysis in patients with transient neurologic

CV: Michael R. Frankel, M.D.

Page - 14

deficits. Neurology, 2001; 57:2125-2128.

29. Patel SC, Levine SR, Tilley BC, Grotta JC, Lu M, Frankel M, et al. for the National

Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of

Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute

Stroke. JAMA 2001; 286(22).

30. Qureshi AI, Mohammad Y, Suri MFK, Braimah J, Janardhan V, Guterman LR, Hopkins

LN, Frankel MR. Cocaine use and hypertension are major risk factors for intracerebral

hemorrhage in young African Americans. Ethnicity & Disease 2001;11:311-319.

31. Bruno A, Levine SR, Frankel MR, et al. Admission Glucose Level and Outcomes in the

NINDS rt-PA Stroke Trial. Neurology 2002;59:669-674.

32. Meschia JF, Brott TG, Brown RG, Crook R, Frankel MR, Hardy J, Merino J, Rich SS,

Silliman S, Worrall B. The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC

(BioMed Central) Neurology 2003, 3:4(8 July 2003).

33. IMS Study Investigators. Combined Intravenous and Intra-Arterial Recanalization for

Acute Ischemic Stroke: The Interventional Management of Stroke Study. Stroke. 2004

Apr;35(4):904-11.

34. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick J, Brott T, Frankel

M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P,

Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S.

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS,

ECASS, and NINDS rt-PA stroke trials. Lancet 2004 Mar 6;363(9411):768-74.

35. Azran MS, Waljee A, Biousse V, Frankel M, Newman NJ. Episodic third nerve palsy

with cryptococcal meningitis. Neurology. 2005 Feb 22;64(4):759-60.

36. Turan TN, Hertzberg V, Weiss P, McClellan W, Presley R, Krompf K, Karp H, and

Frankel MR. Clinical Characteristics of Patients With Early Hospital Arrival After

Stroke Symptom Onset. Journal of Stroke and Cerebrovascular Diseases, Vol. 14, No. 6

(November-December), 2005: pp 272-277.

37. Chimowitz MC, Lynn MS, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et

al. Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis.

N Engl J Med 2005; 352:1305-16.

38. Libman, R.B., Kwiatkowski T, Lyden P, Grotta J, Tilley BC, Fagan, S, Levine, S,

Broderick, J, Lin, Y, Lewandowski C, and Frankel, M. Asymptomatic hemorrhagic

transformation of cerebral infarction does not worsen long -- term outcome. Journal of

Stroke and Cerebrovascular Diseases March - April, 2, 2005, 50-54.

CV: Michael R. Frankel, M.D.

Page - 15

39. Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, Karp H,

LaBresh KA, Malarcher A, Moomaw CJ, Schwamm L, Weiss P; Paul Coverdell

Prototype Registries Writing Group. Acute stroke care in the US: results from 4 pilot

prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005

Jun;36(6):1232-40.

40. The NINDS tPA Stroke Study Group. Recombinant t-PA for minor strokes Ann Emerg

Med 2005;46(3):243-52.

41. Hertzberg V, Weiss P, Stern BJ, and Frankel MR. Family history associated with

improved functional outcome following ischemic stroke. Neuroepidemiology.

2006;27(2):74-80

42. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel

MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ;

Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of

stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation

2006;113:555-563.

43. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel MR, Goldstein FC,

Salomone JP, Dent LL, Harris OA, Ander DS, Lowery DW, Patel MM, Denson DD,

Gordon AB, Wald MM, Gupta S, Hoffman SW, and Stein DG. ProTECT: A

Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury.

Ann Emerg Med. 2006 Sep 28.

44. Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, Hertzberg VS,

Chaturvedi S, Levine SR, Stern BJ, Benesch CG, Jovin TG, Sila CA, Romano JG, for the

Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators.

Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from

WASID. Neurology 2006;67 1275-1278

45. Meschia JF, Case LD, Worrall BB, Brown RD Jr, Brott TG, Frankel M, Silliman S, Rich

SS; Ischemic Stroke Genetics Study Group. Family history of stroke and severity of

neurologic deficit after stroke. Neurology. 2006 Oct 24;67(8):1396-402.

46. Schwamm L, Reeves MJ, Frankel M. Designing a sustainable national registry for stroke

quality improvement. Am J Prev Med 2006 Dec;31(6 Suppl 2):S251-7.

47. Reeves MJ, Broderick JP, Frankel M, LaBresh KA, Schwamm L, Moomaw CJ, Weiss P,

Katzan I; Paul Coverdell Prototype Registries Writing Group, Arora S, Heinrich JP,

Hickenbottom S, Karp H, Malarcher A, Mensah G, Reeves MJ.The Paul Coverdell

National Acute Stroke Registry: initial results from four prototypes. Am J Prev Med 2006

Dec;31(6 Suppl 2):S202-9.

CV: Michael R. Frankel, M.D.

Page - 16

48. Matarín M, Brown WM, Scholz S, Simón-Sánchez J, Fung HC, Hernandez D, Gibbs JR,

De Vrieze FW, Crews C, Britton A, Langefeld CD, Brott TG, Brown RD, Worrall BB,

Frankel M, Silliman S, Case LD, Singleton A, Hardy JA, Rich SS, Meschia JF, A

genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data

release. Lancet Neurology 6:414-20 2007

49. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M,

Chimowitz MI for the WASID Study Group. Risk factor status and vascular events in

patients with symptomatic intracranial stenosis. Neurology 2007;69;2063-2068.

50. Labresh KA, Reeves MJ, Frankel MR, Albright D, and Schwamm LH. Hospital

treatment of patients with ischemic stroke or transient ischemic attack with Get With The

Guidelines. Archives of Internal Medicine. Feb 25, 2008;168(4):411-17.

51. Kleindorfer D, Miller R, Sailor-Smith S, Moomaw CJ, Khoury J, Frankel M.

The challenges of community-based research: the beauty shop stroke education project.

Stroke. 2008 Aug;39(8):2331-5.

52. Waddy SP, Cotsonis G, Lynn MJ, Frankel MR, Chaturvedi S, Williams JE, Chimowitz

M. Racial Differences in Vascular Risk Factors and Outcomes of Patients With

Intracranial Atherosclerotic Arterial Stenosis. Stroke. 2008 Oct 2. [Epub ahead of print]

53. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G,

Cannon CP, Liang L, Peterson E, Labresh KA. Get With the Guidelines-Stroke is

associated with sustained improvement in care for patients hospitalized with acute stroke

or transient ischemic attack. Circulation. 2009 Jan 6;119(1):107-15.

54. Schwamm LH, Audebert HJ, Amarenco P, Chumbler NR, Frankel MR, George MG,

Gorelick PB, Horton KB, Kaste M, Lackland DT, Levine SR, Meyer BC, Meyers PM,

Patterson V, Stranne SK, White CJ, and on behalf of the American Heart Association

Stroke Council; Council on Epidemiology and Prevention; Interdisciplinary Council on

Peripheral Vascular Disease; and the Council on Cardiovascular Radiology and

Intervention . Recommendations for the Implementation of Telemedicine Within Stroke

Systems of Care. A Policy Statement From the American Heart Association

Stroke. Published online, May 7, 2009, doi:10.1161/STROKEAHA.109.192361

55. Rhoney DH, Coplin WM, Lin Y, Frankel M, Lyden PD, Levine SR.Time of day,

outcome, and response to thrombolytic therapy: the National Institute of Neurological

Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial

experience. J Stroke Cerebrovasc Dis. 2010 Jan;19(1):40-8.

56. Famakin B, Weiss P, Hertzberg V, McClellan W, Presley R, Krompf K, Karp H, Frankel

MR. Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia Stroke

Registry. J Stroke Cerebrovasc Dis. 2010 Jan;19(1):17-22

CV: Michael R. Frankel, M.D.

Page - 17

57. Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, Zhao X, Peterson

E, Fonarow GC. Race/ethnicity, quality of care, and outcomes in ischemic stroke.

Circulation. 2010 Apr 6;121(13):1492-501

58. Menon BK, Frankel MR, Liang L, Labresh KA, Ellrodt G, Hernandez AF, Fonarow GC,

Schwamm LH, Smith EE; on behalf of the Get With The Guidelines–Stroke Steering

Committee and Investigators Rapid Change in Prescribing Behavior in Hospitals

Participating in Get With The Guidelines-Stroke After Release of the Management of

Atherothrombosis With Clopidogrel in High-Risk Patients (MATCH) Clinical Trial

Results. Stroke. 2010 Jul 15.

59. Reeves MJ, Gargano J, Maier KS, Broderick JP, Frankel M, LaBresh KA, Moomaw CJ,

Schwamm L.. Patient-level and hospital-level determinants of the quality of acute stroke

care: a multilevel modeling approach. Stroke 2010 Dec;41(12):2924-31.

60. Nahab F, Le A, Judd S, Frankel MR, Ard J, Newby PK, Howard VJ. Racial and

geographic differences in fish consumption: the REGARDS study. Neurology. 2011 Jan

11;76(2):154-8. Epub 2010 Dec 22.

61. Anderson ER, Smith B, Ido M, Frankel M. Remote Assessment of Stroke Using the

iPhone 4. J Stroke Cerebrovasc Dis. 2011 Oct 20. [Epub ahead of print]

PMID:22018507

62. Nahab F, Kingston C, Frankel MR, Dion JE, Cawley CM, Mitchell B, Hammonds LP,

Ayala L, Tong FC. Early Aggressive Medical Management for Patients with Symptomatic

Intracranial Stenosis. J Stroke Cerebrovasc Dis. 2011 Jul 25. [Epub ahead of print]

63. Gupta R, Horev A, Nguyen T, Gandhi D, Wisco D, Glenn BA, Tayal AH, Ludwig B,

Terry JB, Gershon RY, Jovin T, Clemmons PF, Frankel MR, Cronin CA, Anderson AM,

Hussain MS, Sheth KN, Belagaje SR, Tian M, Nogueira RG. Higher volume

endovascular stroke centers have faster times to treatment, higher reperfusion rates and

higher rates of good clinical outcomes. J Neurointerv Surg. 2012 Jul 25. [Epub ahead of

print]

64. SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS,

Pearce LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

N Engl J Med. 2012 Aug 30;367(9):817-25.

65. Sun CH, Nogueira RG, Glenn BA, Connelly K, Zimmermann S, Anda K, Camp D,

Frankel MR, Belagaje SR, Anderson AM, Isakov AP, Gupta R. "Picture to puncture": a

novel time metric to enhance outcomes in patients transferred for endovascular

reperfusion in acute ischemic stroke. Circulation. 2013 Mar 12;127(10):1139-48.

66. Horn CM, Sun CH, Nogueira RG, Patel VN, Krishnan A, Glenn BA, Belagaje SR,

Thomas TT, Anderson AM, Frankel MR, Schindler KM, Gupta R. Endovascular

CV: Michael R. Frankel, M.D.

Page - 18

Reperfusion and Cooling in Cerebral Acute Ischemia (ReCCLAIM I). J Neurointerv

Surg. 2013 Mar 6. [Epub ahead of print]

67. Rangaraju S, Owada K, Noorian R, Nogueira RG, Nahab F, Glenn BA, Belagaje SR,

Anderson AM, Frankel MR, Gupta R. Comparison of Final Infarct Volumes in Patients

Who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial

Large-Vessel Occlusions. JAMA Neurol, Published online May 13, 2013.

[doi:10.1001/jamaneurol.2013.413.]

68. Woo D, Rosand J, Kidwell C, McCauley J, Osborne J, Brown MW, West SE,

Rademacher EW, Waddy S, Roberts JN, Koch S, Gonzales NR, Sung G, Kittner S,

Birnbaum L, Frankel M, Testai FE, Hall C, Elkind M, Flaherty M, Coull B, Chong JY,

Warwick T, Malkoff M, James ML, Ali LK, Worrall B, Jones F, Watson T, Leonard A,

Martinez R, Sacco R and Langefeld CD. The Ethnic/Racial Variations of Intracerebral

Hemorrhage (ERICH) Study Protocol. Stroke, published online Sept 10, 2013.

69. Ivan C. Rokos, Lee H. Schwamm, Madeleine Konig, Mary-Beth Malcarney, Katie B.

Horton, Jeffrey Ranous, A. Gray Ellrodt, Steven A. Farmer, Michael R. Frankel, T.

Bruce Ferguson, David C. Goff, Jr, Loren Hiratzka, Alice K. Jacobs on behalf of the

American Heart Association Advocacy Coordinating Committee. Variable Impact of

State Legislative Advocacy on Registry Participation and Regional Systems of Care

Implementation: A Policy Statement From the American Heart Association. Circulation.

Published on line Sept 16, 2013.

70. Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje S, Anderson A, Frankel M,

Gupta R, Nogueira R. Clinical, angiographic and radiographic outcome differences

among mechanical thrombectomy devices: initial experience of a large-volume center. J

Neurointerv Surg. 2014 Mar 21. doi: 10.1136/neurintsurg-2013-011037. [Epub ahead of

print]

71. Bian F, Simon RP, Li Y, David L, Wainwright J, Hall CL, Frankel M, Zhou A.

Nascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker

discovery in human stroke. Stroke. 2014 Apr;45(4):1177-9. doi:

10.1161/STROKEAHA.113.004576. Epub 2014 Feb 20.

72. Sun CH, Connelly K, Nogueira RG, Glenn BA, Zimmermann S, Anda K, Camp D, Gaunt

S, Pallard H, Eckenroth M, Frankel MR, Belagaje SR, Anderson AM, Nahab F, Yepes

M, Gupta R. ASPECTS decay during inter-facility transfer predicts patient outcomes in

endovascular reperfusion for ischemic stroke: a unique assessment of dynamic

physiologic change over time. J Neurointerv Surg. 2014 Mar 26. doi:

10.1136/neurintsurg-2013-011048. [Epub ahead of print]

73. Belagaje SR, Sun CH, Nogueira RG, Glenn BA, Wuermser LA, Patel V, Frankel MR,

Anderson AM, Thomas TT, Horn CM, Gupta R. Discharge disposition to skilled nursing

facility after endovascular reperfusion therapy predicts a poor prognosis. J Neurointerv

CV: Michael R. Frankel, M.D.

Page - 19

Surg. 2014 Jan 17. doi: 10.1136/neurintsurg-2013-011045. [Epub ahead of print]

74. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J,

Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy

EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG,

Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and

Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis

Trial Investigators. Aggressive medical treatment with or without stenting in high-risk

patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised

trial. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3.

Epub 2013 Oct 26.

75. Rangaraju S, Liggins JT, Aghaebrahim A, Streib C, Sun CH, Gupta R, Nogueira R,

Frankel M, Mlynash M, Lansberg M, Albers G, Jadhav A, Jovin TG. Pittsburgh

outcomes after stroke thrombectomy score predicts outcomes after endovascular therapy

for anterior circulation large vessel occlusions. Stroke. 2014 Aug;45(8):2298-304. PMID:

25005445

76. Rangaraju S, Aghaebrahim A, Streib C, Sun CH, Ribo M, Muchada M, Nogueira R,

Frankel M, Gupta R, Jadhav A, Jovin TG. Pittsburgh Response to Endovascular therapy

(PRE) score: optimizing patient selection for endovascular therapy for large vessel

occlusion strokes. J Neurointerv Surg. 2014 Oct 15, PMID: 25320054

77. Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, Benavente OR;

SPS3 Investigators. Effects of long-term blood pressure lowering and dual antiplatelet

treatment on cognitive function in patients with recent lacunar stroke: a secondary

analysis from the SPS3 randomised trial. Lancet Neurol. 2014 Dec;13(12):1177-85.

78. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein

FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS,

Barsan WG; NETT Investigators. Very early administration of progesterone for acute

traumatic brain injury.N Engl J Med. 2014 Dec 25;371(26):2457-66.

79. Ido MS, Bayakly R, Frankel M, Lyn R, Okosun IS. Administrative data linkage to

evaluate a quality improvement program in acute stroke care, Georgia, 2006-2009. Prev

Chronic Dis. 2015 Jan 15;12:E05.

80. Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje SR, Anderson AM, Frankel

MR, Gupta R, Nogueira RG. Periprocedural cost-effectiveness analysis of mechanical

thrombectomy for acute ischemic stroke in the stent retriever era. Interv Neurol. 2015

Mar;3(2):107-13.

81. Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje S, Anderson A, Frankel M,

Gupta R, Nogueira R. Clinical, angiographic and radiographic outcome differences

among mechanical thrombectomy devices: initial experience of a large-volume center. J

CV: Michael R. Frankel, M.D.

Page - 20

Neurointerv Surg. 2015 Mar;7(3):176-81

82. Haussen DC, Lima A, Frankel M, Anderson A, Belagaje S, Nahab F, Rangaraju S,

Nogueira RG. Sulcal effacement with preserved gray-white junction: a sign of reversible

ischemia. Stroke. 2015 Jun;46(6):1704-6.

83. Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje SR, Anderson AM, Frankel

MR, Gupta R, Nogueira RG. Periprocedural cost-effectiveness analysis of mechanical

thrombectomy for acute ischemic stroke in the stent retriever era. Interv Neurol. 2015

Mar;3(2):107-13

84. Rangaraju S, Streib C, Aghaebrahim A, Jadhav A, Frankel M, Jovin TG. Relationship

Between Lesion Topology and Clinical Outcome in Anterior Circulation Large Vessel

Occlusions. Stroke. 2015 Jul;46(7):1787-92.

REVIEW ARTICLES

Frankel MR, Ischemic Cerebrovascular Disease. Neurosurgical Consultations Vol. 3, #23,

1992.

Qureshi A, Dawson R, Frankel MR and Stern B. Recent Advances in the Management of

Vasospasm in Patients with Subarachnoid Hemorrhage. Neurologist, Jan 96.

Qureshi A and Frankel MR. Diagnosis and Management of Subarachnoid Hemorrhage.

Journal of Heart Disease and Stroke, Sept, Oct 1994.

Frankel MR. Intravenous t-PA for Acute Ischemic Stroke. Neurologist, Sep 96.

Seestedt, Jr RC and Frankel MR, Intracerebral Hemorrhage. Current Treatment Options in

Neurology, 1999, 1:127-137.

Sanders KA and Frankel MR. Stroke care and prevention in Georgia: current status and

challenges. Journal of the Medical Association of Georgia. February, 2001: 29-31.

Thambisetty M, Newman N, Glass J and Frankel MR. A practical approach to the diagnosis

and management of MELAS: Case report and review. The Neurologist 8:302-312:2002.

Frankel MR. Acute Stroke. In: Continuum. American Academy of Neurology CME

publication. Volume 9, number 2, April 2003, pgs 31 – 52.

Frankel MR, Wityk RJ, Pullicino P, and Chan R. Pharmacology of Stroke. In: Continuum.

American Academy of Neurology CME publication. Lippincott Williams and Wilkins Press.

Volume 9, number 2, April 2003, pgs 83 – 96.

JOURNALS EDITED:

CV: Michael R. Frankel, M.D.

Page - 21

Frankel MR and Levine SR. TPA for Acute Stroke: Perspectives after 5 years of use.

Seminars in Cerebrovascular Disease. 2001:1;117-198.

Frankel MR and Levine SR. TPA for Acute Stroke: Perspectives after 5 years of use.

Journal of Cerebrovascular Disease and Stroke. 2002:11;119-203.

BOOK CHAPTERS:

Frankel MR and Mackay B. Large Vessel Occlusive Disease. In: The Medical

Management of the Surgical Patient. Lippincott, Edited by Lubin, M., 1995. Revised

2006.

Frankel MR and Chimowitz M. Acute Stroke. In: Emergency Neurology, Principles and

Practice. Cambridge Press 1999.

Frankel, MR, Arora A, and Badjatia N. Thrombolytic Therapy. In: Neurological

Therapeutics, Principles and Practice. Martin Dunitz Publishers. The Liversy House,

London. Volume 1, 2003:pgs 408 – 419. Revised for 2nd edition, published in 2006.

Frankel, MR and Bichsel, J. Thrombolytic therapy for TIA and mild stroke. In:

Transient Ischemic Attacks. Blackwell Publishing. 2004; pgs 348 - 364.

CDC PUBLICATIONS:

Frankel MR, Hinchey J, Schwamm LH, Wall H, Rose KM, George MG, McGruder HF,

Liban A, Croft JB. Prehospital and Hospital Delays After Stroke Onset --- United States,

2005—2006. MMWR. 2007;56(19):474-478.

SYMPOSIUM CONTRIBUTIONS:

Proceedings from The Rapid Identification and Treatment of Acute Ischemic

Stroke,NINDS,12/96. Web site:

http://www.ninds.nih.gov/health_and_medical/pubs/strokeworkshop.htm

BOOK REVIEWS:

Journal of Neurosurgery, Feb 1994. Review of Transcranial Doppler: A Clinical

Approach by Babikian, et al.

Journal of Neurosurgery. Review of Neurosonology by Tegeler, et al, 1996.

Journal of Neurosurgery. Review of Handbook of Transcranial Doppler by McCartney et

al. 1997.

CV: Michael R. Frankel, M.D.

Page - 22

Neurology. Review of Clinical Practice of Critical Care Neurology by Wijdicks EFM.

April, 1998.

MONOGRAPHS:

Frankel MR, Kothari R. Acute Ischemic Stroke: A New Paradigm. Emory University

School of Medicine, Continuing Medication Education Program. Distributed to

Neurologists and Emergency Physicians in the U.S. in 1998. Produced by Syner Med and

Sponsored by Genentech, Inc.

OTHER PUBLICATIONS:

LETTERS TO EDITOR:

Frankel MR, for the NINDS t-PA Stroke Study Group: Thrombolytic therapy in acute

ischemic stroke. (Letter) New Engl J Med 1997; 336:65.

8/2015